BET-bromodomain inhibitors modulate epigenetic patterns at the diacylglycerol kinase alpha enhancer associated with radiation-induced fibrosis.

MLA

Valinciute, Gintvile, et al. “BET-Bromodomain Inhibitors Modulate Epigenetic Patterns at the Diacylglycerol Kinase Alpha Enhancer Associated with Radiation-Induced Fibrosis.” Radiotherapy & Oncology, vol. 125, no. 1, Oct. 2017, pp. 168–74. EBSCOhost, https://doi.org/10.1016/j.radonc.2017.08.028.

APA

Valinciute, G., Weigel, C., Veldwijk, M. R., Oakes, C. C., Herskind, C., Wenz, F., Plass, C., Schmezer, P., & Popanda, O. (2017). BET-bromodomain inhibitors modulate epigenetic patterns at the diacylglycerol kinase alpha enhancer associated with radiation-induced fibrosis. Radiotherapy & Oncology, 125(1), 168–174. https://doi.org/10.1016/j.radonc.2017.08.028

Chicago

Valinciute, Gintvile, Christoph Weigel, Marlon R. Veldwijk, Christopher C. Oakes, Carsten Herskind, Frederik Wenz, Christoph Plass, Peter Schmezer, and Odilia Popanda. 2017. “BET-Bromodomain Inhibitors Modulate Epigenetic Patterns at the Diacylglycerol Kinase Alpha Enhancer Associated with Radiation-Induced Fibrosis.” Radiotherapy & Oncology 125 (1): 168–74. doi:10.1016/j.radonc.2017.08.028.